Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Complex and Mixed

Explore clinical trials studying Neoplasms, Complex and Mixed. Study availability and eligibility vary by location and protocol.

399 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Complex and Mixed trial results

Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

NCT02114229

Conditions
Atypical Teratoid Rhabdoid Tumor, Malignant Rhabdoid Tumor, Neoplasms, +3 more
Locations
  • Lucille Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, Not Recruiting

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

NCT01025089

Conditions
Clinical Masaoka Stage II to IVA, Hemic and Lymphatic Diseases, Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
View Trial Details

Related conditions